Transitional Drugs 3
A Contract Award Notice
by VELINDRE NHS TRUST, NHS WALES SHARED SERVICES PARTNERSHIP - PROCUREMENT SERVICES (ON BEHALF OF ALL WALES UHBS & TRUSTS
- Source
- Find a Tender
- Type
- Contract (Goods)
- Duration
- not specified
- Value
- £7K-£7M
- Sector
- HEALTH
- Published
- 14 May 2025
- Delivery
- not specified
- Deadline
- n/a
Concepts
Location
Wales:
Geochart for 1 buyers and 11 suppliers
1 buyer
- All Wales Uhbs & Trusts Newport
11 suppliers
- Celltrion Healthcare Uxbridge
- Amgen Cambridge
- Biogen Idec Maidenhead
- Celix Pharma Watford
- Fresenius Kabi Runcorn
- Roche Products Welwyn Garden City
- Sandoz Camberley
- Sun Pharma Uxbridge
- Thornton & Ross Huddersfield
- Tillomed Laboratories St Neots
- Zentiva Guildford
Description
Drugs which have recently lost their patent exclusivity
Total Quantity or Scope
Transitional Drugs 3
Award Detail
1 | Celltrion Healthcare (Uxbridge)
|
2 | Amgen (Cambridge)
|
3 | Biogen Idec (Maidenhead)
|
4 | Celix Pharma (Watford)
|
5 | Fresenius Kabi (Runcorn)
|
6 | Roche Products (Welwyn Garden City)
|
7 | Sandoz (Camberley)
|
8 | Sun Pharma (Uxbridge)
|
9 | Thornton & Ross (Huddersfield)
|
10 | Tillomed Laboratories (St Neots)
|
11 | Zentiva (Guildford)
|
Award Criteria
Product Quality/Acceptability | Pass/Fail |
Financial (overall cost of contract) | 85 |
Social Value/Community Benefits | 15 |
Price | 85 |
CPV Codes
- 33600000 - Pharmaceutical products
Other Information
** PREVIEW NOTICE, please check Find a Tender for full details. **
Reference
- ocds-h6vhtk-04c9a9
- FTS 021504-2025